DK0917463T3 - Tramadol-flerenhedsformuleringer - Google Patents

Tramadol-flerenhedsformuleringer

Info

Publication number
DK0917463T3
DK0917463T3 DK97935532T DK97935532T DK0917463T3 DK 0917463 T3 DK0917463 T3 DK 0917463T3 DK 97935532 T DK97935532 T DK 97935532T DK 97935532 T DK97935532 T DK 97935532T DK 0917463 T3 DK0917463 T3 DK 0917463T3
Authority
DK
Denmark
Prior art keywords
multiple unit
unit formulations
tramadol
tramadol multiple
formulations
Prior art date
Application number
DK97935532T
Other languages
Danish (da)
English (en)
Inventor
Helmut Momberger
Marc Raber
Dieter Kuhn
Wolfgang Schmid
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Application granted granted Critical
Publication of DK0917463T3 publication Critical patent/DK0917463T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
DK97935532T 1996-07-25 1997-07-19 Tramadol-flerenhedsformuleringer DK0917463T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19630035A DE19630035A1 (de) 1996-07-25 1996-07-25 Tramadol Multiple Unit Formulierungen
PCT/EP1997/003934 WO1998004249A2 (de) 1996-07-25 1997-07-19 Tramadol multiple unit formulierungen

Publications (1)

Publication Number Publication Date
DK0917463T3 true DK0917463T3 (da) 2002-06-10

Family

ID=7800815

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97935532T DK0917463T3 (da) 1996-07-25 1997-07-19 Tramadol-flerenhedsformuleringer

Country Status (29)

Country Link
US (2) US5955104A (zh)
EP (1) EP0917463B1 (zh)
JP (1) JP3631762B2 (zh)
KR (1) KR100474793B1 (zh)
CN (1) CN1111402C (zh)
AR (1) AR008002A1 (zh)
AT (1) ATE213408T1 (zh)
AU (1) AU737121B2 (zh)
BG (1) BG63708B1 (zh)
BR (1) BR9710761A (zh)
CA (1) CA2211284C (zh)
CZ (1) CZ296964B6 (zh)
DE (2) DE19630035A1 (zh)
DK (1) DK0917463T3 (zh)
EE (1) EE03742B1 (zh)
ES (1) ES2171268T3 (zh)
HK (1) HK1020876A1 (zh)
HU (1) HU227971B1 (zh)
IL (1) IL127915A (zh)
NO (1) NO324207B1 (zh)
NZ (1) NZ333822A (zh)
PL (1) PL188834B1 (zh)
PT (1) PT917463E (zh)
RU (1) RU2201223C2 (zh)
SK (1) SK285300B6 (zh)
TW (1) TW495363B (zh)
UA (1) UA52679C2 (zh)
WO (1) WO1998004249A2 (zh)
ZA (1) ZA975408B (zh)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
US6197347B1 (en) * 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
DE19901687B4 (de) * 1999-01-18 2006-06-01 Grünenthal GmbH Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
DE19901686A1 (de) 1999-01-18 2000-07-20 Gruenenthal Gmbh Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
CN1202815C (zh) 1999-08-31 2005-05-25 格吕伦塔尔有限公司 含有曲马朵糖精盐的持续释放给药剂型
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
KR20020059653A (ko) * 1999-10-29 2002-07-13 그린 마틴, 브라이언 쥐 테슬리 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6620431B1 (en) 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
JP5014554B2 (ja) * 2000-06-14 2012-08-29 ジェイカムアグリ株式会社 被覆生物活性粒状物の製造方法
EP1296666A2 (en) * 2000-07-06 2003-04-02 Delsys Pharmaceutical Corporation Improved thyroid hormone formulations
HU230686B1 (en) 2000-10-30 2017-08-28 Euro Celtique Sa Controlled release hydrocodone compositions
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
US20030104976A1 (en) * 2001-07-23 2003-06-05 Gudarz Davar Analgesic methods using endothelin receptor ligands
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
US8128957B1 (en) * 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
PT1476138E (pt) * 2002-02-21 2012-02-14 Valeant Internat Barbados Srl Formulações de libertação modificada de pelo menos uma forma de tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
DK1542658T3 (da) * 2002-08-15 2011-04-04 Euro Celtique Sa Farmaceutiske sammensætninger omfattende et opioidanalgetikum
DK1424068T3 (da) * 2002-11-27 2006-11-27 Oramon Arzneimittel Gmbh & Co Fremgangsmåde til fremstilling af pellets indeholdende et tri- eller tetra-cyklisk antidepressivum samt farmaceutiske tilberedninger indeholdende disse pellets
US20060153915A1 (en) * 2003-01-23 2006-07-13 Amorepacific Corporation Sustained-release preparations and method for producing the same
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
US20050053669A1 (en) * 2003-09-05 2005-03-10 Boehringer Ingelheim International Gmbh Administration form for the oral application of poorly soluble acidic and amphorteric drugs
WO2005034859A2 (en) * 2003-10-03 2005-04-21 Elite Laboratories Inc. Extended release formulations of opioids and method of use thereof
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
EP1771159A4 (en) * 2004-07-22 2009-04-29 Amorepacific Corp SLOW RELEASE PREPARATIONS CONTAINING TOPIRAMATE AND PROCESS FOR PRODUCING THE SAME
WO2006028830A2 (en) 2004-09-01 2006-03-16 Euro-Celtique S.A. Opioid dosage forms having dose proportional steady state cave and auc and less than dose proportional single dose cmax
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
RU2401125C2 (ru) 2004-12-27 2010-10-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ стабилизации лекарственного средства против деменции
PL1915137T3 (pl) * 2005-08-10 2014-03-31 Add Advanced Drug Delivery Tech Ltd Preparat doustny o kontrolowanym uwalnianiu
EP1959936A2 (en) * 2005-11-10 2008-08-27 Circ Pharma Research and Development Limited Once-daily administration of central nervous system drugs
US20070185145A1 (en) * 2006-02-03 2007-08-09 Royds Robert B Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration
US20070264335A1 (en) * 2006-05-09 2007-11-15 Sherman Bernard C Modified release tablets comprising tramadol
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
ES2350029T3 (es) * 2007-03-02 2011-01-17 Farnam Companies, Inc. Pellets de liberación sostenida que comprenden un material tipo cera.
US10736850B2 (en) * 2007-08-13 2020-08-11 Ohemo Life Sciences Inc. Abuse resistant oral opioid formulations
CN101095666B (zh) * 2007-08-14 2010-10-06 石药集团欧意药业有限公司 一种盐酸曲马多缓释片剂及其制备方法
CZ300468B6 (cs) * 2007-09-20 2009-05-27 Zentiva, A. S Léková forma obsahující tramadol s kontrolovaným uvolnováním po dobu 24 hodin a zpusob její prípravy
WO2009087690A2 (en) * 2008-01-11 2009-07-16 Jubilant Organosys Limited Multiparticulate extended release pharmaceutical composition of carbamazepine and process for manufacturing the same
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
CN102202654B (zh) * 2008-09-04 2014-07-30 法纳姆公司 可咀嚼的缓释制剂
FR2938431B1 (fr) * 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
DK2358360T3 (en) 2008-11-18 2016-12-12 Ucb Biopharma Sprl EXTENDED release formulations comprising one 2-OXO-1 PYRROLIDIN DERIVATIVE
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
BR112013000190A2 (pt) 2010-07-06 2017-11-07 Gruenenthal Gmbh formas de dosagem de retenção gástrica compreendendo um análogo de gaba e um opioide
PL2872121T3 (pl) 2012-07-12 2019-02-28 SpecGx LLC Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
US20140275038A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
DE4428444A1 (de) * 1994-08-11 1996-02-15 Dresden Arzneimittel Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen

Also Published As

Publication number Publication date
EP0917463A2 (de) 1999-05-26
US6436438B1 (en) 2002-08-20
BR9710761A (pt) 1999-08-17
CA2211284A1 (en) 1998-01-25
AR008002A1 (es) 1999-11-24
SK285300B6 (sk) 2006-10-05
HK1020876A1 (en) 2000-05-26
PL188834B1 (pl) 2005-04-29
HUP9903053A3 (en) 2000-02-28
RU2201223C2 (ru) 2003-03-27
PT917463E (pt) 2002-07-31
BG63708B1 (bg) 2002-10-31
WO1998004249A3 (de) 1998-04-30
ZA975408B (en) 1998-01-05
NO324207B1 (no) 2007-09-10
ES2171268T3 (es) 2002-09-01
KR100474793B1 (ko) 2005-03-08
SK9899A3 (en) 1999-09-10
DE59706441D1 (de) 2002-03-28
NO990261L (no) 1999-01-21
JP2000515871A (ja) 2000-11-28
EE03742B1 (et) 2002-06-17
AU3849197A (en) 1998-02-20
CZ18599A3 (cs) 1999-04-14
PL331387A1 (en) 1999-07-05
NO990261D0 (no) 1999-01-21
HUP9903053A2 (hu) 2000-01-28
IL127915A (en) 2001-08-08
TW495363B (en) 2002-07-21
CA2211284C (en) 2001-10-23
EP0917463B1 (de) 2002-02-20
CZ296964B6 (cs) 2006-08-16
AU737121B2 (en) 2001-08-09
UA52679C2 (uk) 2003-01-15
IL127915A0 (en) 1999-11-30
DE19630035A1 (de) 1998-01-29
US5955104A (en) 1999-09-21
EE9900031A (et) 1999-08-16
ATE213408T1 (de) 2002-03-15
JP3631762B2 (ja) 2005-03-23
CN1111402C (zh) 2003-06-18
NZ333822A (en) 1999-11-29
KR20000029530A (ko) 2000-05-25
HU227971B1 (en) 2012-07-30
WO1998004249A2 (de) 1998-02-05
BG103158A (en) 1999-08-31
CN1226824A (zh) 1999-08-25

Similar Documents

Publication Publication Date Title
DE59706441D1 (de) Tramadol multiple unit formulierungen
MA24473A1 (fr) Formulations
DE69714227T2 (de) Abseilgerät
EE9700138A (et) Aerosoolravimvormid
DK0901753T3 (da) Herbicid sammensætning
BR9708893A (pt) Ferniluracilas substituidas
DE29611266U1 (de) Antiseptikum
NO991430D0 (no) Insektfordrivende formuleringer
BR9603495A (pt) Central elétrica
DE69726475T2 (de) Monitor
DE29614396U1 (de) Bürste
KR950022504U (ko) 구두
DE29702436U1 (de) Fußschalter
FI946210A0 (fi) Paula
IT240904Y1 (it) Griglia per porcilaie
SE9404469D0 (sv) Aerosol formulations
FI3003U1 (fi) Kuormapankka
FIU960242U0 (fi) Kaluste
KR970064203U (ko) 푸셔 유니트
DE29600687U1 (de) Bürste
DE9414885U1 (de) Schuhe
KR960019721U (ko) 신발
KR950026427U (ko) 신발
KR960013126U (ko) 신발
KR960013127U (ko) 신발